Clinical Trial Update: An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast Cancer [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 open-label, multicenter trial evaluating the efficacy and safety of sequential neoadjuvant docetaxel after dox…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Monotaxel (docetaxel)

Snippet

Sponsor: Yonsei University | Conditions: Locally Advanced Breast Cancer | Phase 4 | Status: COMPLETED